Zantac Prostate Cancer Has Men That Used Zantac Worried
Zantac may be more likely to blame for prostate cancer than spicey foods and processed meats
Monday, September 7, 2020 - For years, doctors have blamed processed, spicey deli meats for causing prostate cancer in men. All that time, however, the cancer culprit may have been the medicine doctors recommended for heartburn caused by eating them. Men who have taken the heartburn and acid reflux medication Zantac for heartburn caused by eating processed meats may have developed prostate cancer from regularly using the medicine for an extended period. Researchers fear that Zantac's interaction with nitrites, preservatives in processed meats, could cause NDMA, nitrosimine, to increase to many thousands of times more than the FDA's acceptable limit and cause prostate cancer.
According to Mayo Clinic, "Prostate cancer is cancer that occurs in the prostate - a small walnut-shaped gland in men that produces the seminal fluid that nourishes and transports sperm." Prostate cancer is one of the most feared types of cancer by men aged 50 and above. Treating prostate cancer involves removing the prostate gland which terminates a man's ability to achieve an erection, putting an immediate end to a traditional sexual relationship.
Men need to be concerned that Zantac Prostate cancer may be in its early stages and the symptoms not apparent. Prostate cancer like others has a multi-year latency period when a person has the disease but does not yet know it. It is for that reason that many people let their Zantac prostate cancer go untreated for so long that it spreads to other organs through the bloodstream and becomes difficult to stop without highly toxic chemotherapy. Early diagnosis allows oncologists to target the local cancer cells with radiation and surgically remove them, and stop the spread. Cancer.net encourages men that used Zantac in the past to monitor for the following signs that they may have developed prostate cancer: Frequent urination, weak or interrupted urine flow or the need to strain to empty the bladder, the urge to urinate frequently at night, blood in the urine or seminal fluid, erectile dysfunction and finally pain or burning during urination.
Men with prostate cancer have hired Zantac Prostate Cancer Lawyers and filed personal injury or wrongful death lawsuits seeking monetary compensation for loss of income, reimbursement of medical expenses, and punitive damages for pain and suffering. If the plaintiff in a Zantac cancer lawsuit has died, the deceased's loved ones can file a claim on behalf of the plaintiff's estate.
Law firms around the country have published clients that have filed a Zantac Prostate Cancer lawsuit against French pharmaceutical company Sanofi, the maker of Zantac. Zantac (ranitidine) was the world's best-selling brand of antacid before being recalled by the FDA earlier in the year over cancer concerns. About Lawsuits.com recently published the details of a Zantac Cancer lawsuits filed by a man with prostate cancer in the US state of Florida. " Plaintiff Jack Rhoda indicates that he developed prostate cancer in 2019, after using Zantac for more than eight years. The lawsuit names Sanofi, Sanofi-Aventis, Chattem, Inc, and Boehringer Ingelheim as defendants, claiming that the drug makers knew or should have known for decades that Zantac exposed users to N-Nitrosodimethylamine (NDMA), a known carcinogen."
More Recent Heartburn MedicineLawsuit News:
- Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
- Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
- Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
- The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
- Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
- Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
- Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
- A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
- Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
- Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
- Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
- Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
- The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
- Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
- Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
- Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
- Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
- Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
- Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
- Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022
Lawyers for Zantac Heartburn Medicine Lawsuits
OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.